MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE Trademark

Trademark Overview

On Wednesday, April 13, 2011, a trademark application was filed for MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE with the United States Patent and Trademark Office. The USPTO has given the MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE trademark a serial number of 85293937. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, March 1, 2024. This trademark is owned by Melanoma Research Foundation Breakthrough Consortium, Inc.. The MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of melanoma research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials
melanoma research foundation breakthrough consortium accelerating research for a cure

General Information

Serial Number85293937
Word MarkMELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE
Filing DateWednesday, April 13, 2011
Status800 - REGISTERED AND RENEWED
Status DateFriday, March 1, 2024
Registration Number4403733
Registration DateTuesday, September 17, 2013
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 30, 2012

Trademark Statements

Description of MarkThe mark consists of the words "MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM" stacked vertically above "ACCELERATING RESEARCH FOR A CURE" all to the right of a half-circle with seven radiating lines of dots that progressively diminish in size.
Section 2(f) Limitation Statementas to "MELANOMA RESEARCH FOUNDATION"
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"CONSORTIUM"
Goods and ServicesProviding medical and scientific research information in the field of melanoma research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 18, 2011
Primary Code042
First Use Anywhere DateThursday, February 16, 2012
First Use In Commerce DateThursday, February 16, 2012

Trademark Owner History

Party NameTHE MELANOMA RESEARCH FOUNDATION
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWashington, DC 20005
Party NameTHE MELANOMA RESEARCH FOUNDATION
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWASHINGTON, DC 20005
Party NameTHE MELANOMA RESEARCH FOUNDATION
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressWASHINGTON, DC 20005
Party NameMelanoma Research Foundation Breakthrough Consortium, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWashington, DC 20005

Trademark Events

Event DateEvent Description
Sunday, July 24, 2011PRIORITY ACTION E-MAILED
Saturday, April 16, 2011NEW APPLICATION ENTERED
Monday, April 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, July 19, 2011ASSIGNED TO EXAMINER
Sunday, July 24, 2011PRIORITY ACTION WRITTEN
Sunday, July 24, 2011NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, January 23, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 24, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2012NON-FINAL ACTION WRITTEN
Wednesday, February 15, 2012NON-FINAL ACTION E-MAILED
Wednesday, February 15, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 15, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 16, 2012ASSIGNED TO LIE
Wednesday, August 22, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 24, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 10, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 30, 2012PUBLISHED FOR OPPOSITION
Tuesday, October 30, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 21, 2013TEAS STATEMENT OF USE RECEIVED
Friday, June 21, 2013USE AMENDMENT FILED
Friday, July 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 15, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 8, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 13, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, August 14, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 17, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, May 7, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 7, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 17, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 17, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, October 28, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 28, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, October 28, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, May 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, September 17, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 11, 2023TEAS SECTION 8 & 9 RECEIVED
Friday, March 1, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, March 1, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, March 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, July 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 2, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

research accelerating cure consortium breakthrough foundation melanoma scientific medical trials clinical field information providing conducting namely